FindTrial
Sign In

Study on precise drug therapy for severe patients

Study on precise drug therapy for severe patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066115
Enrollment
Unknown
Registered
2022-11-24
Start date
2022-12-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Serious diseases

Interventions

Intervention group:Precise drug treatment
Routine treatment group:conventional therapy

Sponsors

Fujian Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 18-80; 2. Patient in severe condition.

Exclusion criteria

Exclusion criteria: Death or transfer out within 24 hours after admission.

Design outcomes

Primary

MeasureTime frame
Differential protein;Differential gene;—

Countries

China

Contacts

Public ContactLiming Wang

Fujian Provincial Hospital

wangliming202211@163.com+86 591 88216343

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026